BMC Cardiovascular Disorders is calling for submissions to our Collection on cell and molecular therapy for cardiovascular diseases. Scientists from around the globe are investigating/leveraging cell and molecular-based strategies to protect, regenerate, replace, and restore the function of cardiac and vascular tissue. Advances in basic and clinical research have yielded encouraging findings highlighting the promise of such strategies to treat a range of CVDs. However, gaps in our knowledge remain and further research is required to translate findings from basic research into the clinic.
In support of SDG 3: Good Health & Wellbeing, BMC Cardiovascular Disorders calls for papers exploring the potential of stem cells, gene editing, tissue engineering, disease modeling, and organoids to improve our understanding of cardiovascular diseases and open new avenues for therapeutic intervention.
Dr Sherin Saheera completed her PhD in India in 2017 and went to the US to pursue her postdoctoral studies. After a year of training at the University of Alabama at Birmingham, she is currently working as a Postdoctoral Associate at the University of Massachusetts, Chan Medical School, where she has been since January 2019. She has over 18 publications in peer reviewed high impact journals and has been serving as an editorial board member and reviewer for reputed journals. She has also presented papers in several national and international conferences.
Huiliang Zhang: University of Arkansas for Medical Sciences, US
Dr Zhang’s research focuses on cardiac dysfunction in the aging heart with an emphasis on the pathogenic role of elevated proton leak from mitochondria. He explores the strategies for restoring mitochondrial function and stem cell therapies to reverse cardiac dysfunction in preclinical models of aging. Dr. Zhang is the principal investigator of the NIH R35 grant and the American Heart Association (AHA) Career Development Award. Dr. Zhang served in NIH and AHA study sections. He has nearly 40 original publications and has won several national trainee and junior faculty awards.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.